Assisted Reproductive Technology Market Report 2026 Market Outlook Supported By A Forecast 8.9% CAGR

The assisted reproductive technology sector is on a path of significant expansion as advancements in fertility treatments continue to gain momentum worldwide. With increasing innovations and growing awareness, this market is positioned to experience remarkable growth over the coming years. Let's explore the current market valuation, influential drivers, leading companies, emerging trends, and segment details shaping this evolving industry.

Forecasted Market Size and Growth of the Assisted Reproductive Technology Market
The assisted reproductive technology market is projected to witness robust growth through 2030, reaching a value of $56.96 billion. This expansion corresponds to a compound annual growth rate (CAGR) of 8.9%, fueled by various factors. These include the rising adoption of precision fertility diagnostics, increased investments in fertility treatment infrastructure, the broadening use of genetic testing applications, a growing preference for minimally invasive procedures, and enhanced healthcare spending on reproductive health. Key trends anticipated during this period involve greater uptake of advanced embryo screening methods, expanded use of frozen embryo and egg banking, increased demand for personalized fertility treatments, deeper incorporation of genetic testing within assisted reproductive technology procedures, and a heightened focus on improving treatment success rates.

The assisted reproductive technology market size has grown strongly in recent years. It will grow from $37.06 billion in 2025 to $40.46 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising infertility prevalence, increasing maternal age trends, expansion of fertility clinics, availability of assisted reproductive procedures, growing social acceptance of art treatments.

Download a free sample of the assisted reproductive technology market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Driving Forces Behind the Growth of the Assisted Reproductive Technology Market
The rapid expansion of assisted reproductive technology is largely due to the increasing adoption of cutting-edge fertility diagnostics that provide more precise and reliable information. This advancement is complemented by growing investments aimed at expanding fertility treatment centers and related healthcare infrastructure. Together, these developments make treatments more accessible and effective for a wider patient base.

Additionally, the rising demand for minimally invasive fertility procedures is encouraging market growth. Patients are increasingly seeking treatments that reduce discomfort and recovery time. At the same time, the integration of genetic testing within fertility care offers enhanced diagnostic capabilities to support tailored treatment plans, further stimulating market interest and adoption.

View the full assisted reproductive technology market report:
https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Top Players Steering the Assisted Reproductive Technology Industry
The market features numerous prominent companies actively shaping its trajectory. Leading names include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, and Fertility Centers of Illinois.

A notable industry development occurred in November 2023, when CooperCompanies, a US-based medical device company, acquired Cook Medical's Reproductive Health business in a $300 million deal. This acquisition strengthens CooperSurgical's portfolio of fertility and women's health products, reinforcing its status as a key global provider. Cook Medical, headquartered in the US, is a respected supplier of assisted reproductive technology solutions.

Emerging Innovations and Trends Moving the Assisted Reproductive Technology Market Forward
Leading firms in the assisted reproductive technology space are advancing their offerings by focusing on next-generation sequencing (NGS)-based testing kits. These kits enhance chromosomal analysis and embryo selection, ultimately aiming to boost the success rates of fertility treatments. NGS-based preimplantation genetic testing (PGT) is utilized as a research tool to thoroughly screen embryos for chromosomal abnormalities, aiding informed decisions during IVF and ICSI procedures.

For example, in July 2023, Thermo Fisher Scientific Inc., an American biotechnology firm, introduced two new NGS-based products: the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. These tools are tailored for reproductive health laboratories and represent the first research-use-only products compatible with the Ion Torrent Genexus Integrated Sequencer. This platform facilitates an efficient workflow, from sample processing to aneuploidy analysis. The PGT-A test identifies chromosomal anomalies in embryos, and these innovations are designed to improve pregnancy success and ensure healthier outcomes. Additionally, the Ion AmpliSeq Polyploidy Panel provides enhanced quality control by detecting contamination, preventing sample errors, and identifying triploidy, marking significant technological progress within the industry.

Further Innovations Influencing the Assisted Reproductive Technology Field
Beyond NGS testing, the integration of seamless sequencing, data analysis, and templating through platforms like Genexus simplifies research processes. This streamlining enables laboratories to deliver faster, more accurate results. As companies continue to innovate, there is an increasing focus on developing personalized fertility solutions that cater to individual patient needs, promoting overall treatment efficacy and patient satisfaction.

Detailed Breakdown of Assisted Reproductive Technology Market Segments
This market is broadly segmented according to diagnosis, procedure type, and end-user. The diagnostic category includes hysterosalpingography, ovarian reserve testing, and genetic testing. Procedure types cover fresh non-donor, fresh donor, frozen donor, frozen non-donor, and embryo or egg banking. End-users are classified as hospitals, fertility clinics, and other relevant medical facilities.

These segments are further divided into subcategories such as:
- Hysterosalpingography (HSG), which includes X-ray HSG and sonohysterography (SHG)
- Ovarian reserve testing, comprising follicle stimulating hormone (FSH) testing, anti-Müllerian hormone (AMH) testing, and antral follicle count (AFC) via ultrasound
- Genetic testing, featuring preimplantation genetic testing (PGT), carrier screening tests, and genetic compatibility testing.

This comprehensive segmentation allows for a detailed analysis of market dynamics and helps identify specific areas of demand and growth potential within the assisted reproductive technology industry.

New analytical features added to our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.